๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Principles of Clinical Pharmacology || The Role of the FDA in Guiding Drug Development

โœ Scribed by Sahajwalla, Chandrahas G.


Book ID
118182884
Publisher
Elsevier
Year
2012
Tongue
English
Weight
97 KB
Edition
3
Category
Article
ISBN
0123854717

No coin nor oath required. For personal study only.

โœฆ Synopsis


Principles of Clinical Pharmacology is a successful survey covering the pharmacologic principles underlying the individualization of patient therapy and contemporary drug development. This essential reference continues to focus on the basics of clinical pharmacology for the development, evaluation, and clinical use of pharmaceutical products while also addressing the most recent advances in the field. Written by leading experts in academia, industry, clinical and regulatory settings, the third edition has been thoroughly updated to provide readers with an ideal reference covering the wide range of important topics impacting clinical pharmacology as the discipline plays an increasingly significant role in drug development and regulatory science.

The Third Edition has been endorsed by the American Society for Clinical Pharmacology and Therapeutics

* Includes new chapters on imaging and the pharmacogenetic basis of adverse drug reactions. * Offers an expanded regulatory section that addresses US and international issues and guidelines. * Provides extended coverage of earlier chapters on transporters, pharmacogenetics and biomarkers and also illustrates the impact of gender on drug response. * Presents a broadened discussion of clinical trials from Phase 1 to incorporate Phases II and III.


๐Ÿ“œ SIMILAR VOLUMES


Principles of Clinical Pharmacology || N
โœ Takimoto, Chris H. ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› Elsevier ๐ŸŒ English โš– 378 KB

***Principles of Clinical Pharmacology*** is a successful survey covering the pharmacologic principles underlying the individualization of patient therapy and contemporary drug development. This essential reference continues to focus on the basics of clinical pharmacology for the development, evalua

Drug development in inflammatory bowel d
โœ Conor Lahiff; Sunanda Kane; Alan C. Moss ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 198 KB ๐Ÿ‘ 2 views

All medicinal compounds sold in the United States for inflammatory bowel disease (IBD) are regulated by the Food and Drug Administration (FDA) via a number of regulations dating back to 1906. The primary contemporary role of the FDA is in the assessment of safety and efficacy, and subsequent marketi